Crucell News
Most Popular Crucell Story
Wyeth in talks to buy vaccine maker Crucell
It didn't take long for a new deal to surface in the new year. Wyeth is in buyout talks with the Dutch vaccine company Crucell, reportedly for as much as $1.35 billion. Though Crucell sent out a... Read more...
Latest Headlines
- August 17, 2009
- January 7, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
